Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulant Therapy”

364 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 364 results

Large-scale testing (Phase 3)Ended earlyNCT00484822
What this trial is testing

Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)

Who this might be right for
Long-term Oral Anticoagulant Therapy
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 206
Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Not applicableStudy completedNCT01109667
What this trial is testing

Differences in Coagulation Test Kits

Who this might be right for
Effect of Different Reagents.Oral Anticoagulant Therapy
Yuksek Ihtisas Hospital 350
Not applicableLooking for participantsNCT07083609
What this trial is testing

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Who this might be right for
Cerebral Venous Thrombosis
Hieu Trung Dinh 69
Post-approval studies (Phase 4)Looking for participantsNCT06401616
What this trial is testing

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

Who this might be right for
Atrial FibrillationLeft Atrial Appendage AbsentAnticoagulant Adverse Reaction
Odense University Hospital 1,220
Large-scale testing (Phase 3)Study completedNCT00740493
What this trial is testing

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

Who this might be right for
Recurrent Venous ThromboembolismIdiopathic Deep Vein Thrombosis
University Hospital, Brest 104
Not applicableStudy completedNCT04234698
What this trial is testing

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Who this might be right for
Atrial Fibrillation
Pfizer 2,076
Testing effectiveness (Phase 2)WithdrawnNCT04275778
What this trial is testing

HYDROxychloroquine in Syndrome Primary AntiPhospholipid

Who this might be right for
Antiphospholipid Syndrome in PregnancyAnticoagulants
Assistance Publique - Hôpitaux de Paris
Not applicableStudy completedNCT04998799
What this trial is testing

Practice Variation on Antithrombotics in COVID-19

Who this might be right for
COVID-19 PneumoniaThrombosisCOVID-19 Acute Respiratory Distress Syndrome+1 more
NMC Specialty Hospital 435
Testing effectiveness (Phase 2)Study completedNCT00320255
What this trial is testing

Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Who this might be right for
ThrombosisCancerPulmonary Embolism
Bristol-Myers Squibb 130
Large-scale testing (Phase 3)Study completedNCT00970619
What this trial is testing

DUTCH CAVA-trial: CAtheter Versus Anticoagulation Alone for Acute Primary (Ilio)Femoral DVT.

Who this might be right for
Acute Thrombosis of Deep Veins of Proximal Lower Extremity
Maastricht University Medical Center 184
Large-scale testing (Phase 3)UnknownNCT00125671
What this trial is testing

Warfarin and Antiplatelet Vascular Evaluation

Who this might be right for
Peripheral Vascular DiseasesCardiovascular Diseases
Anand, Sonia, M.D. 2,400
Not applicableActive Not RecruitingNCT05038228
What this trial is testing

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Who this might be right for
Atrial Fibrillation
Pfizer 1
Large-scale testing (Phase 3)Looking for participantsNCT05387954
What this trial is testing

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Who this might be right for
Cryptogenic Ischemic StrokePatent Foramen Ovale
Assistance Publique - Hôpitaux de Paris 792
Large-scale testing (Phase 3)Study completedNCT02798471
What this trial is testing

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Pulmonary EmbolismDeep Vein Thrombosis (DVT)
Daiichi Sankyo 290
Not applicableLooking for participantsNCT07458191
What this trial is testing

Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
Bosnalijek D.D 800
Not applicableUnknownNCT04419012
What this trial is testing

Polish Atrial Fibrillation (POL-AF) Registry

Who this might be right for
Atrial Fibrillation
Jan Kochanowski University 4,000
Post-approval studies (Phase 4)Looking for participantsNCT07132515
What this trial is testing

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Who this might be right for
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University 100
Large-scale testing (Phase 3)Study completedNCT02664649
What this trial is testing

Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis

Who this might be right for
Symptomatic Aortic StenosisEligible for Transcatheter Aortic Valve Replacement
Assistance Publique - Hôpitaux de Paris 1,510
Post-approval studies (Phase 4)Study completedNCT04724460
What this trial is testing

Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer

Who this might be right for
Venous ThrombosisNeoplasmsAnticoagulants
Takeshi Morimoto 179
Load More Results